ZBIO Stock: Price, Earnings History and SEC Filings
Zenas BioPharma, Inc. (ZBIO) last traded at $28.39, down 1.29% on the latest session and up 5.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.77 against an analyst estimate of $-0.89, a miss of 98.9%.
$28.39 -1.29%
1 month+5.27%
52-week high$44.60
52-week low$13.50
Volume358,070
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ZBIO earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 13, 2026 | $-1.77 | $-0.89 | -98.88% |
| Mar 2026 | May 13, 2026 | $-1.46 | $-1.37 | -6.57% |
| Dec 2025 | Mar 16, 2026 | $-4.54 | $-1.22 | -272.13% |
| Sep 2025 | Nov 12, 2025 | $-1.22 | $-0.87 | -40.23% |
ZBIO beat the analyst EPS estimate in 0 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for ZBIO
SEC filing data is not available right now. You can search for ZBIO on SEC EDGAR.
ZBIO news
- Zenas BioPharma Eyes Key Lupus and IL-17 Data as Obexelimab FDA Decision NearsOct 30, 2026 · marketbeat.com
- Wall Street Analysts Predict a 77.61% Upside in Zenas BioPharma, Inc. (ZBIO): Here's What You Should KnowOct 23, 2026 · finance.yahoo.com
- Zenas BioPharma Stock Gains Attention After Long Term Trial DataOct 21, 2026 · finance.yahoo.com
About Zenas BioPharma, Inc.
Zenas BioPharma, Inc. (ZBIO) is a US-listed public company on Nasdaq.